Boback Ziaeian MD PhD
Echocardiography, Non-Invasive Cardiology, Preventive Cardiology
Assistant Professor
Join to View Full Profile
100 UCLA Medical PlzSte 630Los Angeles, CA 90024
Phone+1 310-825-9011
Fax+1 310-825-2092
Dr. Ziaeian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Ronald Reagan UCLA Medical CenterPost-Doctoral Fellowship, 2013 - 2016- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Cardiovascular Disease, 2012 - 2016
Yale-New Haven Medical CenterResidency, Internal Medicine, 2008 - 2011
University of California, Irvine, School of MedicineClass of 2008
Certifications & Licensure
CA State Medical License 2011 - 2027
CT State Medical License 2011 - 2012
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
National Board of EchocardiographyDiplomate
Publications & Presentations
PubMed
- National Differences in Trends for Heart Failure Hospitalizations by Sex and Race/Ethnicity.Manyoo A Agarwal, Pratyakash K Srivastava, Carolyn S P Lam, Gregg C Fonarow, Boback Ziaeian
Circulation. Heart Failure. 2025-09-24 - Disparities in Heart Failure Epidemiology, Diagnosis, Management, and Outcomes.Amy R Yan, Pratyaksh K Srivastava, Darko Vucicevic, Manyoo A Agarwal, Boback Ziaeian
Cureus. 2025-09-01 - Variation in mechanical circulatory support use for acute myocardial infarction cardiogenic shock.Arjun Verma, Nikhil L Chervu, Justin J Kim, Saad Mallick, Boback Ziaeian
Heart. 2025-08-24
Journal Articles
- National Trends in Heart Failure Hospitalizations and Readmissions from 2010 to 2017Manyoo A Agarwal, Gregg C Fonarow, Boback Ziaeian, JAMA Cardiology
- Association of Optimal Implementation of Sodium-Glucose Cotransporter 2 Inhibitor Therapy with Outcome for Patients with Heart FailureBoback Ziaeian, Clyde W Yancy, JAMA Cardiology
- Perceived Barriers to Sacubitril/Valsartan Use in Patients with Heart FailureKevin S Shah, Boback Ziaeian, Freny V Mody, Ali Nsair, Gregg C Fonarow, Journal of Cardiac Failure
- Join now to see all
Authored Content
- Association of Optimal Implementation of Sodium-Glucose Cotransporter 2 Inhibitor Therapy with Outcome for Patients with Heart FailureMay 2020
- Perceived Barriers to Sacubitril/Valsartan Use in Patients with Heart FailureAugust 2018
Press Mentions
More Americans Hospitalized, Readmitted for Heart FailureFebruary 16th, 2021- Surgisphere Data Used in Two COVID Studies Called into QuestionJune 3rd, 2020
Arterial Thrombosis in Patients with CancerApril 7th, 2020- Join now to see all
Other Languages
- Spanish, Farsi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
